Related Experiment Video
Updated: Jul 14, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Matrix fibronectin binds gammaretrovirus and assists in entry: new light on viral infections
Christiane Beer1, Lene Pedersen
1Department of Molecular Biology, Aarhus University, C. F. Møllers Allé, Building 130, DK-8000 Aarhus C, Denmark.
Abstract:
A major entry route for the gammaretrovirus amphotropic murine leukemia virus (A-MLV) into NIH 3T3 fibroblasts is via caveola-dependent endocytosis. However, during the infection time, few viral particles can be observed intracellularly. Analyzing the dynamics of the A-MLV infection process by using total internal reflection fluorescence microscopy, we show that the majority of viruses are extracellular and bound to the fibronectin matrix. Moreover, the amounts of bound virus and of fibronectin correlated. Using confocal microscopy, nanoparticles targeted to fibronectin by a III1C-fibronectin fragment or anti-fibronectin antibody were detected intracellularly in NIH 3T3 cells; unconjugated nanoparticles neither bound to cells nor were detectable intracellularly. Furthermore, A-MLV colocalized intracellularly with the fibronectin-targeted nanoparticles, suggesting that they were taken up by the same cellular pathway. Both A-MLV entry and fibronectin turnover depend on caveolar endocytosis, and we found that inhibiting viral binding to the extracellular NIH 3T3 fibronectin-matrix dramatically reduced A-MLV infection, indeed, showing an active role of fibronectin in infection. We suggest that binding to the cellular fibronectin matrix provides a new mechanism by which viruses can enter cells.
Insights
Amphotropic murine leukemia virus (A-MLV) uses the fibronectin matrix to enter cells via caveola-dependent endocytosis. Inhibiting this viral binding significantly reduced infection, highlighting fibronectin's active role.
Area of Science:
- Virology
- Cell Biology
- Biochemistry
Background:
- Amphotropic murine leukemia virus (A-MLV) enters NIH 3T3 fibroblasts through caveola-dependent endocytosis.
- Few viral particles are typically observed intracellularly during infection.
- The role of the extracellular matrix in viral entry remains incompletely understood.
Purpose of the Study:
- To investigate the dynamics of A-MLV infection and the role of the fibronectin matrix.
- To elucidate the cellular uptake pathway of A-MLV in relation to fibronectin.
Main Methods:
- Total internal reflection fluorescence microscopy to analyze viral dynamics.
- Confocal microscopy to track nanoparticle and viral colocalization.
- Inhibition of viral binding to fibronectin to assess infection rates.
Main Results:
- The majority of A-MLV particles were found extracellularly, bound to the fibronectin matrix.
- A correlation was observed between bound virus amounts and fibronectin levels.
- Fibronectin-targeted nanoparticles were internalized by NIH 3T3 cells, colocalizing with A-MLV.
- Inhibiting viral binding to fibronectin significantly reduced A-MLV infection.
Conclusions:
- Fibronectin matrix binding is a crucial mechanism for A-MLV cell entry.
- A-MLV utilizes caveola-dependent endocytosis, engaging with the fibronectin matrix.
- This interaction plays an active and significant role in the viral infection process.
Related Concept Videos
Fibronectins Connect Cells with ECM
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Retroviruses

